ARQT logo

ARQT
Arcutis Biotherapeutics Inc

2,475
Mkt Cap
$2.98B
Volume
1.11M
52W High
$31.77
52W Low
$11.86
PE Ratio
-171.34
ARQT Fundamentals
Price
$24.00
Prev Close
$23.97
Open
$23.57
50D MA
$26.98
Beta
1.40
Avg. Volume
1.41M
EPS (Annual)
-$0.1269
P/B
15.60
Rev/Employee
$1.06M
$3,587.81
Loading...
Loading...
News
all
press releases
GW&K Investment Management LLC Sells 206,391 Shares of Arcutis Biotherapeutics, Inc. $ARQT
GW&K Investment Management LLC decreased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 15.0% during the third quarter, according to its most recent filing...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) CFO Latha Vairavan Sells 2,853 Shares
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) CFO Latha Vairavan sold 2,853 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...
MarketBeat·3d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 3,687 Shares
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Larry Todd Edwards sold 3,687 shares of Arcutis Biotherapeutics stock in a transaction dated Monday, March 2nd. The shares were...
MarketBeat·3d ago
News Placeholder
Masaru Matsuda Sells 3,325 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Masaru Matsuda sold 3,325 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The stock was sold...
MarketBeat·3d ago
News Placeholder
Patrick Burnett Sells 6,287 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Patrick Burnett sold 6,287 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an...
MarketBeat·3d ago
News Placeholder
Masaru Matsuda Sells 8,733 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Masaru Matsuda sold 8,733 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at...
MarketBeat·3d ago
News Placeholder
Insider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 37,349 Shares of Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Todd Watanabe sold 37,349 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an...
MarketBeat·3d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 6.9% After Analyst Downgrade
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 6.9% on Analyst Downgrade...
MarketBeat·5d ago
News Placeholder
Mizuho Has Lowered Expectations for Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price
Mizuho reduced their price objective on Arcutis Biotherapeutics from $37.00 to $35.00 and set an "outperform" rating on the stock in a research note on Monday...
MarketBeat·5d ago
News Placeholder
Research Analysts Offer Predictions for ARQT Q1 Earnings
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) - Analysts at HC Wainwright reduced their Q1 2026 EPS estimates for Arcutis Biotherapeutics in a research note issued to investors on...
MarketBeat·5d ago
<
1
2
...
>

Latest ARQT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.